Researchers at the Eye Clinic of the University Hospital Bonn (UKB) and the University of Bonn, together with colleagues from the University of Münster and Harvard Medical School, have developed an innovative platform that allows the function of neural networks to be studied in a targeted manner.
For the first time, a team of Inserm researchers from the Physics for Medicine Institute (Inserm/ESPCI Paris-PSL/CNRS) has succeeded in mapping the blood flow of an entire organ in animals (heart, kidney and liver) with great precision, in four dimensions: 3D and time.
Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to traditional, human-led programs in adults.
A team of researchers led by Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt University, have developed a magnetic robotic valve to provide minimally invasive intervention for gastroesophageal reflux disease and possibly other organ system disorders.
EPFL researchers have invented a remarkably small and ultraflexible neurovascular microcatheter. Powered by blood flow, it can safely navigate the most intricately branched arteries in a matter of seconds.
Diane Chan, a former research scientist in The Picower Institute for Learning and Memory and neurologist at Massachusetts General Hospital, is the study’s lead and co-corresponding author. Picower Professor Li-Huei Tsai, director of The Picower Institute and the Aging Brain Initiative at MIT, is the study’s senior and co-corresponding author.
Blood tests are among the most common tools in medicine. Scientists are working to make blood cell imaging faster and more intuitive so that doctors can make fast and accurate diagnostic decisions.
The device has shown to be advantageous for individuals with neurological or orthopaedic disorders.
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.